Short answer
SELECT MEDICAL HOLDINGS CORP (SEM) filed an 8-K current report with the SEC on April 30, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure/Election of Directors or Officers), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Section 2.02 contains only a legal safe-harbor and incorporation disclaimer.
SELECT MEDICAL HOLDINGS CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Section 2.02 contains only a legal safe-harbor and incorporation disclaimer
- No earnings figures, reporting period, or operating results available in the provided text
Item 5.02 · Departure/Election of Directors or Officers
- Vesting deferred one year for 304,001 executive equity-award shares
- Executive Chairman Robert A. Ortenzio: 190,000 shares shifted to 2027 vesting dates
- Senior EVP Martin F. Jackson: 114,001 shares shifted to 2027 vesting dates
- Awards remain contingent on continued service through the deferred vesting dates
- Deferral strengthens retention incentives but postpones executives’ equity liquidity and potential dilution timing
Item 8.01 · Other Events
- Quarterly cash dividend declared at $0.0625 per share
- Payment scheduled for or about May 28, 2026
- May 14, 2026 record date determines shareholder eligibility
- Dividend declaration signals continued capital return to shareholders
Item EX-99.1 · Exhibit EX-99.1
- Q1 revenue rose 5.0% to $1,421.5M, but net income fell 14.7% to $63.8M and EPS declined to $0.35
- Adjusted EBITDA decreased 6.5% to $141.6M, signaling margin pressure despite top-line growth
- Rehabilitation hospitals outperformed with revenue up 14.5% and Adjusted EBITDA up 15.1% to $81.1M
- Critical illness and outpatient segments weakened, with Adjusted EBITDA down 15.3% and 9.4%, respectively
- Proposed $16.50-per-share cash merger remains targeted for mid-2026; HSR waiting period expired April 27, 2026, but approvals remain outstanding
- Board declared $0.0625-per-share dividend payable May 28, 2026; 2026 outlook maintained at $5.6B-$5.8B revenue and $520M-$540M Adjusted EBITDA
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SELECT MEDICAL HOLDINGS CORP 8-K filings
Get the next SEM 8-K as it lands
Follow SEM for push alerts, or ask the research agent what this filing means.